img

Global Treatment-Resistant Hypertension Management Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Treatment-Resistant Hypertension Management Market Research Report 2024

The management of Treatment-Resistant Hypertension typically involves the use of multiple classes of antihypertensive medications, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).
According to Mr Accuracy reports’s new survey, global Treatment-Resistant Hypertension Management market is projected to reach US$ 184.7 million in 2029, increasing from US$ 58 million in 2022, with the CAGR of 17.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Treatment-Resistant Hypertension Management market research.
The treatment-resistant hypertension management market is driven by the increasing prevalence of hypertension that does not respond to conventional antihypertensive treatments. Treatment-resistant hypertension refers to persistently high blood pressure despite the use of multiple medications. As the incidence of hypertension continues to rise, there is a growing need for effective management strategies to control blood pressure and reduce the risk of cardiovascular complications. The market is propelled by advancements in medical technology, the development of novel therapies, and a focus on individualized treatment plans. However, the market also faces challenges, including the complexity of managing multiple medications, potential side effects of advanced treatments, and the need for better patient compliance and adherence to therapies. To succeed in this market, healthcare providers and manufacturers must collaborate to develop innovative and patient-friendly treatment approaches that improve blood pressure control and enhance patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Treatment-Resistant Hypertension Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Janssen Biotech
Quantum Genomics
CinCor Pharma
Ionis Pharmaceuticals
Vifor Pharma
KBP Biosciences
Abbott
Kona Medical
Medtronic
Segment by Type
Diuretic Therapy
Combination Therapy
Mineralocorticoid Receptor Antagonists

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Treatment-Resistant Hypertension Management report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment-Resistant Hypertension Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diuretic Therapy
1.2.3 Combination Therapy
1.2.4 Mineralocorticoid Receptor Antagonists
1.3 Market by Application
1.3.1 Global Treatment-Resistant Hypertension Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Treatment-Resistant Hypertension Management Market Perspective (2018-2029)
2.2 Treatment-Resistant Hypertension Management Growth Trends by Region
2.2.1 Global Treatment-Resistant Hypertension Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Treatment-Resistant Hypertension Management Historic Market Size by Region (2018-2024)
2.2.3 Treatment-Resistant Hypertension Management Forecasted Market Size by Region (2024-2029)
2.3 Treatment-Resistant Hypertension Management Market Dynamics
2.3.1 Treatment-Resistant Hypertension Management Industry Trends
2.3.2 Treatment-Resistant Hypertension Management Market Drivers
2.3.3 Treatment-Resistant Hypertension Management Market Challenges
2.3.4 Treatment-Resistant Hypertension Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment-Resistant Hypertension Management Players by Revenue
3.1.1 Global Top Treatment-Resistant Hypertension Management Players by Revenue (2018-2024)
3.1.2 Global Treatment-Resistant Hypertension Management Revenue Market Share by Players (2018-2024)
3.2 Global Treatment-Resistant Hypertension Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Treatment-Resistant Hypertension Management Revenue
3.4 Global Treatment-Resistant Hypertension Management Market Concentration Ratio
3.4.1 Global Treatment-Resistant Hypertension Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment-Resistant Hypertension Management Revenue in 2022
3.5 Treatment-Resistant Hypertension Management Key Players Head office and Area Served
3.6 Key Players Treatment-Resistant Hypertension Management Product Solution and Service
3.7 Date of Enter into Treatment-Resistant Hypertension Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment-Resistant Hypertension Management Breakdown Data by Type
4.1 Global Treatment-Resistant Hypertension Management Historic Market Size by Type (2018-2024)
4.2 Global Treatment-Resistant Hypertension Management Forecasted Market Size by Type (2024-2029)
5 Treatment-Resistant Hypertension Management Breakdown Data by Application
5.1 Global Treatment-Resistant Hypertension Management Historic Market Size by Application (2018-2024)
5.2 Global Treatment-Resistant Hypertension Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Treatment-Resistant Hypertension Management Market Size (2018-2029)
6.2 North America Treatment-Resistant Hypertension Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Treatment-Resistant Hypertension Management Market Size by Country (2018-2024)
6.4 North America Treatment-Resistant Hypertension Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Treatment-Resistant Hypertension Management Market Size (2018-2029)
7.2 Europe Treatment-Resistant Hypertension Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Treatment-Resistant Hypertension Management Market Size by Country (2018-2024)
7.4 Europe Treatment-Resistant Hypertension Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Treatment-Resistant Hypertension Management Market Size (2018-2029)
8.2 Asia-Pacific Treatment-Resistant Hypertension Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Treatment-Resistant Hypertension Management Market Size by Region (2018-2024)
8.4 Asia-Pacific Treatment-Resistant Hypertension Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Treatment-Resistant Hypertension Management Market Size (2018-2029)
9.2 Latin America Treatment-Resistant Hypertension Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Treatment-Resistant Hypertension Management Market Size by Country (2018-2024)
9.4 Latin America Treatment-Resistant Hypertension Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment-Resistant Hypertension Management Market Size (2018-2029)
10.2 Middle East & Africa Treatment-Resistant Hypertension Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Treatment-Resistant Hypertension Management Market Size by Country (2018-2024)
10.4 Middle East & Africa Treatment-Resistant Hypertension Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen Biotech
11.1.1 Janssen Biotech Company Detail
11.1.2 Janssen Biotech Business Overview
11.1.3 Janssen Biotech Treatment-Resistant Hypertension Management Introduction
11.1.4 Janssen Biotech Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.1.5 Janssen Biotech Recent Development
11.2 Quantum Genomics
11.2.1 Quantum Genomics Company Detail
11.2.2 Quantum Genomics Business Overview
11.2.3 Quantum Genomics Treatment-Resistant Hypertension Management Introduction
11.2.4 Quantum Genomics Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.2.5 Quantum Genomics Recent Development
11.3 CinCor Pharma
11.3.1 CinCor Pharma Company Detail
11.3.2 CinCor Pharma Business Overview
11.3.3 CinCor Pharma Treatment-Resistant Hypertension Management Introduction
11.3.4 CinCor Pharma Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.3.5 CinCor Pharma Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Detail
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Introduction
11.4.4 Ionis Pharmaceuticals Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Vifor Pharma
11.5.1 Vifor Pharma Company Detail
11.5.2 Vifor Pharma Business Overview
11.5.3 Vifor Pharma Treatment-Resistant Hypertension Management Introduction
11.5.4 Vifor Pharma Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.5.5 Vifor Pharma Recent Development
11.6 KBP Biosciences
11.6.1 KBP Biosciences Company Detail
11.6.2 KBP Biosciences Business Overview
11.6.3 KBP Biosciences Treatment-Resistant Hypertension Management Introduction
11.6.4 KBP Biosciences Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.6.5 KBP Biosciences Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Treatment-Resistant Hypertension Management Introduction
11.7.4 Abbott Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.7.5 Abbott Recent Development
11.8 Kona Medical
11.8.1 Kona Medical Company Detail
11.8.2 Kona Medical Business Overview
11.8.3 Kona Medical Treatment-Resistant Hypertension Management Introduction
11.8.4 Kona Medical Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.8.5 Kona Medical Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Treatment-Resistant Hypertension Management Introduction
11.9.4 Medtronic Revenue in Treatment-Resistant Hypertension Management Business (2018-2024)
11.9.5 Medtronic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Treatment-Resistant Hypertension Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Diuretic Therapy
Table 3. Key Players of Combination Therapy
Table 4. Key Players of Mineralocorticoid Receptor Antagonists
Table 5. Global Treatment-Resistant Hypertension Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Treatment-Resistant Hypertension Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Treatment-Resistant Hypertension Management Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Treatment-Resistant Hypertension Management Market Share by Region (2018-2024)
Table 9. Global Treatment-Resistant Hypertension Management Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Treatment-Resistant Hypertension Management Market Share by Region (2024-2029)
Table 11. Treatment-Resistant Hypertension Management Market Trends
Table 12. Treatment-Resistant Hypertension Management Market Drivers
Table 13. Treatment-Resistant Hypertension Management Market Challenges
Table 14. Treatment-Resistant Hypertension Management Market Restraints
Table 15. Global Treatment-Resistant Hypertension Management Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Treatment-Resistant Hypertension Management Market Share by Players (2018-2024)
Table 17. Global Top Treatment-Resistant Hypertension Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment-Resistant Hypertension Management as of 2022)
Table 18. Ranking of Global Top Treatment-Resistant Hypertension Management Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Treatment-Resistant Hypertension Management Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Treatment-Resistant Hypertension Management Product Solution and Service
Table 22. Date of Enter into Treatment-Resistant Hypertension Management Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Treatment-Resistant Hypertension Management Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Treatment-Resistant Hypertension Management Revenue Market Share by Type (2018-2024)
Table 26. Global Treatment-Resistant Hypertension Management Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Treatment-Resistant Hypertension Management Revenue Market Share by Type (2024-2029)
Table 28. Global Treatment-Resistant Hypertension Management Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Treatment-Resistant Hypertension Management Revenue Market Share by Application (2018-2024)
Table 30. Global Treatment-Resistant Hypertension Management Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Treatment-Resistant Hypertension Management Revenue Market Share by Application (2024-2029)
Table 32. North America Treatment-Resistant Hypertension Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Treatment-Resistant Hypertension Management Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Treatment-Resistant Hypertension Management Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Treatment-Resistant Hypertension Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Treatment-Resistant Hypertension Management Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Treatment-Resistant Hypertension Management Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Treatment-Resistant Hypertension Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Treatment-Resistant Hypertension Management Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Treatment-Resistant Hypertension Management Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Treatment-Resistant Hypertension Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Treatment-Resistant Hypertension Management Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Treatment-Resistant Hypertension Management Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Treatment-Resistant Hypertension Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Treatment-Resistant Hypertension Management Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Treatment-Resistant Hypertension Management Market Size by Country (2024-2029) & (US$ Million)
Table 47. Janssen Biotech Company Detail
Table 48. Janssen Biotech Business Overview
Table 49. Janssen Biotech Treatment-Resistant Hypertension Management Product
Table 50. Janssen Biotech Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 51. Janssen Biotech Recent Development
Table 52. Quantum Genomics Company Detail
Table 53. Quantum Genomics Business Overview
Table 54. Quantum Genomics Treatment-Resistant Hypertension Management Product
Table 55. Quantum Genomics Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 56. Quantum Genomics Recent Development
Table 57. CinCor Pharma Company Detail
Table 58. CinCor Pharma Business Overview
Table 59. CinCor Pharma Treatment-Resistant Hypertension Management Product
Table 60. CinCor Pharma Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 61. CinCor Pharma Recent Development
Table 62. Ionis Pharmaceuticals Company Detail
Table 63. Ionis Pharmaceuticals Business Overview
Table 64. Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Product
Table 65. Ionis Pharmaceuticals Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 66. Ionis Pharmaceuticals Recent Development
Table 67. Vifor Pharma Company Detail
Table 68. Vifor Pharma Business Overview
Table 69. Vifor Pharma Treatment-Resistant Hypertension Management Product
Table 70. Vifor Pharma Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 71. Vifor Pharma Recent Development
Table 72. KBP Biosciences Company Detail
Table 73. KBP Biosciences Business Overview
Table 74. KBP Biosciences Treatment-Resistant Hypertension Management Product
Table 75. KBP Biosciences Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 76. KBP Biosciences Recent Development
Table 77. Abbott Company Detail
Table 78. Abbott Business Overview
Table 79. Abbott Treatment-Resistant Hypertension Management Product
Table 80. Abbott Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. Kona Medical Company Detail
Table 83. Kona Medical Business Overview
Table 84. Kona Medical Treatment-Resistant Hypertension Management Product
Table 85. Kona Medical Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 86. Kona Medical Recent Development
Table 87. Medtronic Company Detail
Table 88. Medtronic Business Overview
Table 89. Medtronic Treatment-Resistant Hypertension Management Product
Table 90. Medtronic Revenue in Treatment-Resistant Hypertension Management Business (2018-2024) & (US$ Million)
Table 91. Medtronic Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment-Resistant Hypertension Management Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Treatment-Resistant Hypertension Management Market Share by Type: 2022 VS 2029
Figure 3. Diuretic Therapy Features
Figure 4. Combination Therapy Features
Figure 5. Mineralocorticoid Receptor Antagonists Features
Figure 6. Global Treatment-Resistant Hypertension Management Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Treatment-Resistant Hypertension Management Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Treatment-Resistant Hypertension Management Report Years Considered
Figure 12. Global Treatment-Resistant Hypertension Management Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Treatment-Resistant Hypertension Management Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Treatment-Resistant Hypertension Management Market Share by Region: 2022 VS 2029
Figure 15. Global Treatment-Resistant Hypertension Management Market Share by Players in 2022
Figure 16. Global Top Treatment-Resistant Hypertension Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment-Resistant Hypertension Management as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Treatment-Resistant Hypertension Management Revenue in 2022
Figure 18. North America Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Treatment-Resistant Hypertension Management Market Share by Country (2018-2029)
Figure 20. United States Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Treatment-Resistant Hypertension Management Market Share by Country (2018-2029)
Figure 24. Germany Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Treatment-Resistant Hypertension Management Market Share by Region (2018-2029)
Figure 32. China Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Treatment-Resistant Hypertension Management Market Share by Country (2018-2029)
Figure 40. Mexico Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Treatment-Resistant Hypertension Management Market Share by Country (2018-2029)
Figure 44. Turkey Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Treatment-Resistant Hypertension Management Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Janssen Biotech Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 47. Quantum Genomics Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 48. CinCor Pharma Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 50. Vifor Pharma Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 51. KBP Biosciences Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 52. Abbott Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 53. Kona Medical Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 54. Medtronic Revenue Growth Rate in Treatment-Resistant Hypertension Management Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries